Last updated at 13 Oct 2025 10:31 AM
Director
DIN: 07101697
Akshita Pankilkumar Shah is currently associated with 4 companies in various capacities such as Director, Designated Partner and Individual Subscriber. They serve as a Director at TWILIGHT REALITY & DEVELOPERS PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 07101697.Akshita Pankilkumar Shah is currently involved in 3 different roles. Their most recent position is with FLOURISH PHARMA LIMITED as a Individual Subscriber. The first company Akshita Pankilkumar Shah was appointed to as a director was TWILIGHT REALITY & DEVELOPERS PRIVATE LIMITED. Akshita Pankilkumar Shah is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Akshita Pankilkumar Shah is currently associated with 4 companies in various capacities such as Director, Designated Partner and Individual Subscriber. They serve as a Director at TWILIGHT REALITY & DEVELOPERS PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 07101697.Akshita Pankilkumar Shah is currently involved in 3 different roles. Their most recent position is with FLOURISH PHARMA LIMITED as a Individual Subscriber. The first company Akshita Pankilkumar Shah was appointed to as a director was TWILIGHT REALITY & DEVELOPERS PRIVATE LIMITED. Akshita Pankilkumar Shah is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
4
Female
India
Gain instant access to verified contact details.
Current Companies (2)
Current LLPs (2)
Past Companies (0)
2y 2m 1y 1m Interval
Company Name | Designation | Date of Appointment |
---|---|---|
TWILIGHT REALITY & DEVELOPERS PRIVATE LIMITED | Director | 19-Feb-2015 |
FLOURISH PHARMA LIMITED | Individual Subscriber | 01-Aug-2025 |